The Risk of Anticoagulant and Antiplatelet Drugs for Primary Prophylaxis of Cardiovascular Disease in Jails and Prisons

Autor: Donald Venes
Rok vydání: 2015
Předmět:
Zdroj: Journal of Correctional Health Care. 21:309-309
ISSN: 1940-5200
1078-3458
DOI: 10.1177/1078345815588845
Popis: The recently published report by Henning and colleagues (2015) provides strong evidence that prisoners are a population uniquely predisposed to serious injuries, especially those caused by interpersonal violence. In their retrospective study of inmates admitted to the Bellevue Hospital prison ward, 251 patients were admitted for traumatic injuries during a 3-year period. Of these, 142 injuries resulted from ‘‘assault with a fist’’ and 59 injuries resulted from ‘‘slips/falls’’ or sports per patient report. The study by Henning and colleagues expressly excluded patients admitted after ingestion or implantation of foreign bodies. Although Henning and colleagues report no deaths in their population, and no stabbing or slashing injuries, 213 of the wounded prisoners on whom they report required operative intervention. These data, and the data quoted by the authors in their references (e.g., City of New York Department of Correction, 2007), clearly point to a risk for hemorrhage, injury, and surgery in prisoners that greatly exceeds the rate in the general population. Aspirin, warfarin, and other antiplatelet and anticoagulant drugs are often prescribed to inmates in an effort to decrease the risk of cardiovascular events in prisoners with risk factors such as hypertension or hyperlipidemia. The most common and most salient adverse effect of these drugs is bleeding. Given the concentration of injuries among inmates in American jails and prisons, the putative benefits of these drugs for primary prophylaxis of myocardial infarction and stroke are likely to be outweighed by the risks of bleeding caused by serious, and occasionally life-threatening, trauma.
Databáze: OpenAIRE